Raymond James Financial’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.3M Sell
71,028
-1,199
-2% -$86.3K ﹤0.01% 2686
2026
Q1
$5.14M Sell
72,227
-919
-1% -$62.8K ﹤0.01% 2572
2025
Q4
$4.33M Sell
73,146
-1,614
-2% -$87.6K ﹤0.01% 2634
2025
Q3
$4.13M Sell
74,760
-6,884
-8% -$358K ﹤0.01% 2601
2025
Q2
$3.52M Buy
81,644
+14,086
+21% +$543K ﹤0.01% 2627
2025
Q1
$2.67M Sell
67,558
-6,493
-9% -$287K ﹤0.01% 2784
2024
Q4
$3.02M Buy
+74,051
New +$3.08M ﹤0.01% 2669

Other funds holding NGVT

Raymond James Financial's NGVT Position: Q2 2026 in Review

Raymond James Financial reduced its Ingevity (NGVT) stake by 1.7% in Q2 2026, selling an estimated $86.3K and leaving 71,028 shares worth $5.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2686.

Raymond James Financial first reported a position in NGVT in Q4 2024 and has held it in 7 quarters since. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Raymond James Financial held 71,028 shares of Ingevity worth $5.3M as of Q2 2026.
  • Raymond James Financial sold 1,199 Ingevity shares in Q2 2026, an estimated $86.3K.
  • Ingevity made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2686 holding.
  • Raymond James Financial first reported a position in Ingevity in Q4 2024 and has held it in 7 quarters since.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.